Equitable Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.3M | Buy |
92,927
+4,415
| +5% | +$489K | 0.08% | 198 |
|
2025
Q1 | $9.92M | Buy |
88,512
+2,728
| +3% | +$306K | 0.09% | 187 |
|
2024
Q4 | $7.92M | Sell |
85,784
-683
| -0.8% | -$63.1K | 0.08% | 211 |
|
2024
Q3 | $7.25M | Buy |
86,467
+22,560
| +35% | +$1.89M | 0.07% | 216 |
|
2024
Q2 | $4.38M | Buy |
63,907
+1,427
| +2% | +$97.9K | 0.05% | 288 |
|
2024
Q1 | $4.58M | Buy |
62,480
+405
| +0.7% | +$29.7K | 0.05% | 258 |
|
2023
Q4 | $5.03M | Buy |
62,075
+518
| +0.8% | +$42K | 0.06% | 225 |
|
2023
Q3 | $4.61M | Buy |
61,557
+2,090
| +4% | +$157K | 0.07% | 211 |
|
2023
Q2 | $4.58M | Buy |
59,467
+4,024
| +7% | +$310K | 0.07% | 204 |
|
2023
Q1 | $4.6M | Buy |
55,443
+6,656
| +14% | +$552K | 0.07% | 186 |
|
2022
Q4 | $4.19M | Buy |
48,787
+763
| +2% | +$65.5K | 0.07% | 178 |
|
2022
Q3 | $2.96M | Sell |
48,024
-204
| -0.4% | -$12.6K | 0.06% | 212 |
|
2022
Q2 | $2.98M | Buy |
48,228
+520
| +1% | +$32.1K | 0.06% | 207 |
|
2022
Q1 | $2.84M | Buy |
47,708
+6,864
| +17% | +$408K | 0.05% | 227 |
|
2021
Q4 | $2.97M | Sell |
40,844
-409
| -1% | -$29.7K | 0.05% | 223 |
|
2021
Q3 | $2.88M | Buy |
41,253
+156
| +0.4% | +$10.9K | 0.05% | 215 |
|
2021
Q2 | $2.83M | Buy |
41,097
+599
| +1% | +$41.2K | 0.05% | 209 |
|
2021
Q1 | $2.62M | Buy |
40,498
+5,797
| +17% | +$375K | 0.06% | 200 |
|
2020
Q4 | $2.02M | Sell |
34,701
-1,003
| -3% | -$58.4K | 0.05% | 220 |
|
2020
Q3 | $2.26M | Buy |
35,704
+1,535
| +4% | +$97K | 0.06% | 188 |
|
2020
Q2 | $2.63M | Sell |
34,169
-1,141
| -3% | -$87.8K | 0.08% | 160 |
|
2020
Q1 | $2.64M | Buy |
35,310
+1,940
| +6% | +$145K | 0.09% | 133 |
|
2019
Q4 | $2.17M | Buy |
+33,370
| New | +$2.17M | 0.06% | 179 |
|